Canadian Pharma, Biotech and Life Sciences Stocks

50 top Canadian stock picks for 2019 as chosen by the pros

Last year was a rough one for investors, with markets turning in their worst performance in 10 years. And volatility promises to be a constant challenge for investors in 2019. But where there is upheaval there is also opportunity, and the drop in valuations means there are potential bargains to be ...

Canopy Growth and Cronos Group will “dominate” the global market, CIBC says

Canadian banks are getting behind cannabis, with the latest effort coming from CIBC, which Thursday launched coverage of the sector, issuing “Outperform” ratings to industry heavyweights Canopy Growth Corp. (Canopy Growth Stock Quote, Chart TSX:WEED, NYSE:CGC) and Cronos Group (Cronos Group Sto ...

Profound Medical still has a huge upside, says Paradigm Capital

Paradigm Capital analyst Rahul Sarugaser is calling 2019 a breakout year for medical device company Profound Medical (Profound Medical Stock Quote, Chart TSX:PRN), who’s recent rally is only the beginning, the analyst says. “PRN’s stock price has risen from its low of $0.43 on December 20, 20 ...

Canopy Growth Corp has truly global ambitions, CEO Bruce Linton says

Canopy Growth Corp’s (Canopy Growth Corp Stock Quote, Chart TSX:WEED, NYSE:CGC) new expansion into the US has gotten a lot of attention from investors this week but for CEO and co-founder Bruce Linton, it’s all part of his plan to bring his Canadian-tested business model to the rest of the worl ...

Cannabis in the news January 16, 2019

Read Next Article → News on cannabis stocks and on developments in the industry haven’t let up in today’s volatile markets. Here are the stories that we believe will mean most to you as a Canadian investor. 1. Canopy Growth Corp. is making a federally-sanctioned move into the U.S. with its pl ...

Canopy Growth Corp gets new $70.00 price target at GMP Securities

Canopy Growth Corp’s (Canopy Growth Corp Stock Quote, Chart TSX:WEED, NYSE:CGC) entrance into the US hemp market has spurred analyst Martin Landry of GMP Securities to double his international sales forecasts for the cannabis company while upping his target price, reaffirming his “Buy” recomm ...

Echelon Wealth Partners reveals its Top Stock Picks for 2019

Profound Medical Corp. (Profound Medical Stock Quote, Chart TSX:PRN), kneat.com (kneat.com Stock Quote, Chart TSXV:KSI) and Photon Control (Photon Control Stock Quote, Chart TSX:PHO) are head of the class for this quarter’s crop of Top Picks from investment firm Echelon Wealth Partners. For Q1, E ...

There’s still tons of upside in Acerus Pharmaceuticals, Mackie Research says

Specialty pharma company Acerus Pharmaceuticals (Acerus Pharmaceuticals Stock Quote, Chart TSX:ASP) has reported an anticipated shortage in its menopause drug Estrace, an event which will have long-term implications for the company’s sales, says Mackie Research analyst André Uddin. Acerus’s Es ...

Medical cannabis companies will be the clear winners in the pot sector, Paradigm Capital says

Aphria’s (Aphria Stock Quote, Chart TSX, NYSE:APHA) latest earnings report is a sign that cannabis companies focusing more on the medical marijuana market may do better than companies with all their eggs in the rec weed basket, according to sector analyst Rahul Sarugaser of Paradigm Capital. Amid ...

Aphria CEO Neufeld says his departure has nothing to do with short sellers

There’s no date set for his exit but Aphria (Aphria Stock Quote, Chart TSX, NYSE:APHA) CEO Vic Neufeld has announced that he and co-founder Cole Cacciavillan will be stepping down from their executive roles, with Neufeld citing health and personal reasons. “It was just time for us to move aside ...